Drug Management of Prostate Cancer

Nonfiction, Health & Well Being, Medical, Specialties, Urology, Oncology
Cover of the book Drug Management of Prostate Cancer by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781603278294
Publisher: Springer New York Publication: September 14, 2010
Imprint: Springer Language: English
Author:
ISBN: 9781603278294
Publisher: Springer New York
Publication: September 14, 2010
Imprint: Springer
Language: English

Prostate cancer is the most common noncutaneous prostate cancer. Research has revealed several distinct malignancy and the second leading cause of cancer mechanisms of castration-resistant disease that may deaths among men in the United States. It is a critical converge in patients with disease progression on public health problem and remains incurable in the ADT. Many approaches are currently being evaluated metastatic setting with mortality that usually occurs as to improve the treatment of this condition and these a result of castration-resistant disease. fndings have identifed several potential targets for Since Huggins and Hodges’ report of the dra- therapeutic intervention. These include drugs that are matic clinical effects of suppressing serum testos- more active or less toxic chemotherapy agents; drugs terone levels in men with advanced prostate cancer that induce androgen deprivation; drugs that target in 1941, hormone therapy (also called androgen the androgen receptor and/or androgen synthesis; deprivation therapy [ADT]) has become widely drugs that target specifc pathways, including ang- accepted as the mainstay of therapy for the treat- genesis and tyrosine kinase inhibitors, endothelin ment of advanced prostate cancer. ADT combined antagonists and matrix metalloproteinase inhibitors; with radiation therapy is a standard of care in the and immunologic approaches. Many of these agents treatment of men with locally advanced prostate seem promising and the rationale and effcacy of cancer on the basis of evidence that shows improved these emerging therapies remain to be validated in survival. The role of ADT in the management of future clinical trials.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Prostate cancer is the most common noncutaneous prostate cancer. Research has revealed several distinct malignancy and the second leading cause of cancer mechanisms of castration-resistant disease that may deaths among men in the United States. It is a critical converge in patients with disease progression on public health problem and remains incurable in the ADT. Many approaches are currently being evaluated metastatic setting with mortality that usually occurs as to improve the treatment of this condition and these a result of castration-resistant disease. fndings have identifed several potential targets for Since Huggins and Hodges’ report of the dra- therapeutic intervention. These include drugs that are matic clinical effects of suppressing serum testos- more active or less toxic chemotherapy agents; drugs terone levels in men with advanced prostate cancer that induce androgen deprivation; drugs that target in 1941, hormone therapy (also called androgen the androgen receptor and/or androgen synthesis; deprivation therapy [ADT]) has become widely drugs that target specifc pathways, including ang- accepted as the mainstay of therapy for the treat- genesis and tyrosine kinase inhibitors, endothelin ment of advanced prostate cancer. ADT combined antagonists and matrix metalloproteinase inhibitors; with radiation therapy is a standard of care in the and immunologic approaches. Many of these agents treatment of men with locally advanced prostate seem promising and the rationale and effcacy of cancer on the basis of evidence that shows improved these emerging therapies remain to be validated in survival. The role of ADT in the management of future clinical trials.

More books from Springer New York

Cover of the book Female Prisoners, AIDS, and Peer Programs by
Cover of the book Social Information Processing and Survey Methodology by
Cover of the book 3,000 Deep-Sky Objects by
Cover of the book Enzymes in Anesthesiology by
Cover of the book Scheduling and Congestion Control for Wireless Internet by
Cover of the book Practical Imaging Informatics by
Cover of the book Human Development and Criminal Behavior by
Cover of the book Cesarean Section by
Cover of the book Propagation Engineering in Radio Links Design by
Cover of the book Hip Joint Restoration by
Cover of the book Essentials of Vascular Surgery for the General Surgeon by
Cover of the book Bleomycin: Chemical, Biochemical, and Biological Aspects by
Cover of the book Finance with Monte Carlo by
Cover of the book Video Image Detection Systems Installation Performance Criteria by
Cover of the book New Agents for the Treatment of Acute Lymphoblastic Leukemia by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy